论文部分内容阅读
目的探讨肾衰宁胶囊联合血液透析治疗慢性肾衰竭患者的临床效果。方法将80例慢性肾衰竭患者按随机数字表法分为两组,研究组患者采用肾衰宁胶囊联合血液透析治疗,对照组患者仅进行血液透析治疗。比较两组患者的疗效及血生化指标变化情况。结果研究组患者治疗后血肌酐、尿素氮浓度低于对照组;且血红蛋白浓度、肌酐清除率高于对照组,差异均有统计学意义(均P<0.05);研究组患者治疗总有效率为90.0%,明显高于对照组的65.0%,差异有统计学意义(P<0.05)。结论肾衰宁胶囊联合血液透析治疗慢性肾衰竭临床效果较佳。
Objective To investigate the clinical effect of Shenshuaining Capsule combined with hemodialysis on patients with chronic renal failure. Methods Eighty patients with chronic renal failure were divided into two groups according to random number table. The patients in the study group were treated with Shenshuaining capsule and hemodialysis, while the control group were treated with hemodialysis only. The curative effect and the change of blood biochemistry index of two groups were compared. Results The serum creatinine and blood urea nitrogen in the study group were lower than those in the control group after treatment. The hemoglobin concentration and creatinine clearance rate in the study group were significantly higher than those in the control group (all P <0.05). The total effective rate of the study group was 90.0%, which was significantly higher than that of the control group (65.0%), the difference was statistically significant (P <0.05). Conclusion Shenshuaining capsule combined hemodialysis treatment of chronic renal failure clinical effect is better.